Verrica Pharmaceuticals Inc. (VRCA) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $211K. Most recent filing: Aug. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 18, 2026 filed Aug. 17, 2026 | Zawitz David Chief Operating Officer | +$29,880 | 6,000 | +29% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 14, 2026 | Rieger Jayson CEO and President | +$125,750 | 25,000 | +14% | No | |
|
|
||||||
| Aug. 18, 2026 | Kirby John J. Interim CFO | +$24,650 | 5,000 | +26% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Rosenberg Noah L. CMO | +$30,610 | 6,230 | +264% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free